articles

ShareProphets Share Tips of the year number 20: Buy Amryt Pharma says Tom Winnifrith

Tom Winnifrith Tuesday 3 January 2017

 

Share this

Boy did Amryt bore its loyal shareholders, including us, to tears for most of 2016. Owning this stock, formerly a failed oil explorer Fastnet, was like watching paint dry. Amid a totally understandable ennui the shares drifted back to lows of just under 14p which - as we had tipped the shares at 18.4p and bought ourselves at higher levels - was a bit of a pain. But then in November it roared into life and the shares are now 18.5p-20.5p and are my second buy tip of the year at up to 22p.

Read the full article on ShareProphets | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Read next

BREAKING: Versarien Patrick Abbott update – oh dear he now faces up to 20 years in jail, lawyer quits

Oh dear, oh Dear. You may remember how on March 21, Versarien (VRS) announced with great fanfate that it had appointed Patrick Abbott to spearhead its US expansion. Lucian Miers then pointed out that Mr Abbott faced a few legal problems. And so on April 4 Versarien stated:

On ShareProphets
Saturday 15 June 2019
TomWinnifrith.com Copyright © . All rights reserved.
Created by Everywhen